Skip to main content
Prenetics Global Limited (PRE)
NASDAQ: PRE · IEX Real-Time Price · USD
3.190
+0.040 (1.27%)
At close: Apr 18, 2024, 4:00 PM
3.250
+0.060 (1.88%)
After-hours: Apr 18, 2024, 4:35 PM EDT

Prenetics Global Revenue

In the year 2023, Prenetics Global had annual revenue of $21.74M with 65.17% growth. Revenue in the quarter ending December 31, 2023 was $5.43M with 90.84% year-over-year growth.

Revenue (ttm)
$21.74M
Revenue Growth
+65.17%
P/S Ratio
1.78
Revenue / Employee
$54,357
Employees
400
Market Cap
38.70M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202321.74M8.58M65.17%
Dec 31, 202213.16M-262.69M-95.23%
Dec 31, 2021275.85M210.67M323.22%
Dec 31, 202065.18M55.95M605.93%
Dec 31, 20199.23M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cara Therapeutics 20.97M
ImmuCell 17.47M
Marker Therapeutics 3.31M
Lucid Diagnostics 2.43M
Clene 654.00K
Revenue Rankings

PRE News

More News